These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
543 related items for PubMed ID: 10397217
1. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Marik PE, Abraham G, Careau P, Varon J, Fromm RE. Crit Care Med; 1999 Jun; 27(6):1128-31. PubMed ID: 10397217 [Abstract] [Full Text] [Related]
3. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study. Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D, Catheter-Related Infections in ICU (CRI-ICU) Group. Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583 [Abstract] [Full Text] [Related]
4. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Ranucci M, Isgrò G, Giomarelli PP, Pavesi M, Luzzani A, Cattabriga I, Carli M, Giomi P, Compostella A, Digito A, Mangani V, Silvestri V, Mondelli E, Catheter Related Infection Trial (CRIT) Group. Crit Care Med; 2003 Jan; 31(1):52-9. PubMed ID: 12544993 [Abstract] [Full Text] [Related]
5. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Bach A, Eberhardt H, Frick A, Schmidt H, Böttiger BW, Martin E. Crit Care Med; 1999 Mar; 27(3):515-21. PubMed ID: 10199530 [Abstract] [Full Text] [Related]
6. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EA. J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696 [Abstract] [Full Text] [Related]
7. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, Lherm T, Santoli F, Naija W, Riou B. Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256 [Abstract] [Full Text] [Related]
8. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. Ann Intern Med; 1997 Aug 15; 127(4):267-74. PubMed ID: 9265425 [Abstract] [Full Text] [Related]
9. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Maki DG, Stolz SM, Wheeler S, Mermel LA. Ann Intern Med; 1997 Aug 15; 127(4):257-66. PubMed ID: 9265424 [Abstract] [Full Text] [Related]
10. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K, Brun-Buisson C. Crit Care Med; 1996 Nov 15; 24(11):1818-23. PubMed ID: 8917031 [Abstract] [Full Text] [Related]
11. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Appelgren P, Ransjö U, Bindslev L, Espersen F, Larm O. Crit Care Med; 1996 Sep 15; 24(9):1482-9. PubMed ID: 8797619 [Abstract] [Full Text] [Related]
12. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Collin GR. Chest; 1999 Jun 15; 115(6):1632-40. PubMed ID: 10378561 [Abstract] [Full Text] [Related]
13. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients. Vallés J, Fernández I, Alcaraz D, Chacón E, Cazorla A, Canals M, Mariscal D, Fontanals D, Morón A. Infect Control Hosp Epidemiol; 2008 Sep 15; 29(9):847-53. PubMed ID: 18665819 [Abstract] [Full Text] [Related]
14. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT. Diagn Microbiol Infect Dis; 2000 Sep 15; 38(1):1-5. PubMed ID: 11025176 [Abstract] [Full Text] [Related]
15. Prevention of neonatal late-onset sepsis associated with the removal of percutaneously inserted central venous catheters in preterm infants. Hemels MA, van den Hoogen A, Verboon-Maciolek MA, Fleer A, Krediet TG. Pediatr Crit Care Med; 2011 Jul 15; 12(4):445-8. PubMed ID: 21263371 [Abstract] [Full Text] [Related]
16. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R. Crit Care Med; 2006 Mar 15; 34(3):668-75. PubMed ID: 16505651 [Abstract] [Full Text] [Related]
17. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Tennenberg S, Lieser M, McCurdy B, Boomer G, Howington E, Newman C, Wolf I. Arch Surg; 1997 Dec 15; 132(12):1348-51. PubMed ID: 9403542 [Abstract] [Full Text] [Related]
18. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. León C, Ruiz-Santana S, Rello J, de la Torre MV, Vallés J, Alvarez-Lerma F, Sierra R, Saavedra P, Alvarez-Salgado F, Cabaña Study Group. Intensive Care Med; 2004 Oct 15; 30(10):1891-9. PubMed ID: 15278273 [Abstract] [Full Text] [Related]
19. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM, Edwards LP, O'Connell FM, Puyana JC, Doern GV. Arch Intern Med; 1998 Jan 12; 158(1):81-7. PubMed ID: 9437382 [Abstract] [Full Text] [Related]
20. [Causative agents of intravenous catheter-related infections and their antibiotic susceptibilities]. Aktaş E, Sarı EN, Seremet Keskin A, Pişkin N, Külah C, Cömert F. Mikrobiyol Bul; 2011 Jan 12; 45(1):86-92. PubMed ID: 21341163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]